Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Epidermal growth factor receptor erbB1 inhibitor PubMed Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glioblastoma 2 D005909 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650290